Horizon Therapeutics's total assets for Q2 2023 were $9.30B, an increase of 3.39% from the previous quarter. DE:HPR total liabilities were $3.99B for the fiscal quarter, a 2.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.